About half of all melanoma patients have a mutated BRAF gene. This mutation tells the cell to continue to grow.
将近半数的黑色素瘤患者都有BRAF基因突变，从而导致黑色素肿瘤细胞继续生长。
2
Roche's vemurafenib attacks advanced melanoma by blocking the mutated form of a gene, B-RAF.
罗氏公司的vemurafenib通过阻断一种突变的基因b - raf攻击晚期黑色素瘤。
3
Plexxikon was able to develop the drug because researchers using a gene sequencing machine had mapped the genomes of melanoma cells and found a key mutation.